Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEGAA
NCT07521189Recruiting
- Start
- Oct 2025
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Open-label trial (4 arms). Primary endpoint: Pea amino acid bioavailability at 8 hours. Started Oct 2025; status: recruiting.
Beyond the preview
Go deeper on NCT07521189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07521189.